HOME
COMPANY
NEWS
TECHNOLOGY
SERVICES
CONTACT
More
Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment.
Sci Rep. 2019
Kim HJ, Kim BG, Park JE, Ki CS, Huh J, Youm JB, Kang JS, Cho H.